Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Uveitis
•
Inflammatory eye disorders
•
Pediatric Rheumatology
•
Pediatric Ophthalmology
What are the current recommendations for the management of pediatric non-infectious uveitis?
How do you sequence topical corticosteroids, conventional DMARDs and biologics?
Related Questions
How do you approach management autoimmune lymphoproliferative syndrome (ALPS) complicated by HLH?
How would you approach management of a patient with sJIA that was previously well controlled on tocilizumab but is now having ongoing joint disease activity?
In a young patient who was vaccinated to chickenpox as a child (no previous varicella infection) should the patient receive a shingles vaccine prior to starting Rinvoq?
How do you approach a patient with idiopathic anterior uveitis who has ongoing disease despite adalimumab every two weeks?
What are your preferred alternative biologic agents for Blau Syndrome when anti-TNFα therapies are contraindicated?
How do you approach the management of a patient with psoriasis and chronic anterior uveitis who is unable to take DMARDs and has tried TNF inhibitors and IL-17 inhibitors but has ongoing bilateral anterior uveitis?
In the evaluation of a child with recurrent parotitis, is a minor salivary gland biopsy sufficient to assess for Sjogren’s disease, IgG4-related disease and sarcoidosis, or is parotid gland biopsy preferred for diagnostic yield?
When would you consider use of emapalumab for HLH/MAS?
For patients with evidence of prior bilateral uveitis (PS, pupillary membranes, inactive KP, no view posteriorly) who reports no prior symptoms and who has had negative lab work-up, when do you consider repeat work-up and which labs would you repeat?
How would you approach a patient with the diagnosis of Yao Syndrome with manifestations including dermatitis, arthralgia, severe keratoconjunctivitis sicca, and gastroparesis who has failed to respond to dupilumab and canakinumab?